Skip to content

Laparoscopic Single-site Surgery Versus Conventional Entry in Ovarian Cystectomy

Laparoendoscopic Single-site Surgery Versus Conventional Multi-port Laparoscopy in Presumed Benign Ovarian Cystectomy: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04788498
Enrollment
74
Registered
2021-03-09
Start date
2021-05-01
Completion date
2023-05-01
Last updated
2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cyst Benign

Brief summary

The aim of this work is to evaluate the postoperative consequences of laparoendoscopic single site surgery relative to conventional laparoscopy in presumed benign ovarian cyst. The hypothesis is that single incision technique might offer advantages over the standard multi-port laparoscopy as potentially leading to less postoperative pain and improved cosmoses from a relatively hidden umbilical scar, as well as risk reduction of postoperative wound infection, hernia formation and elimination of multiple trocar site closure

Interventions

PROCEDURELaparoendoscpoic single site surgery LESS

• A SILS Port (Covidien®) with three access inlets will be inserted into the abdominal cavity using a Heaney clamp

PROCEDUREConventional multiport laparoscopy

• It will be performed using a three-port system using a closed technique on the umbilicus, left and right lower quadrant area.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* The patients are aged 18 to 45 years with BMI \< 35 kg/m2 and that they exhibit a surgical indication for a presumed benign ovarian pathology (PBOP) according to RCOG Guideline no. 62. 2011: * simple ovarian cysts \>7cm and \<15cm. * Persistent simple cyst for more than 3 months. * Symptomatic patients with complicated cyst (e.g. hemorrhagic cyst, torsion, etc)

Exclusion criteria

* • Previous midline laparotomies as suspected massive adhesions affecting intraoperative maneuvers and time. * Chronic pelvic pain, endometriosis or pelvic inflammatory diseases will be excluded to avoid pelvic adhesions and bias in the quantification of postoperative pain. * Do not possess a native umbilicus giving difficult access to single port. * The 'risk of malignancy index' (RMI) should be used to exclude those women at greater risk of malignancy. Using an RMI cut-off of 200, a sensitivity of 70% and specificity of 90% can be achieved. if features suggestive of malignancy are encountered, a gynecological oncologist should be consulted regarding further evaluation and staging. * Benign teratomas for the difficulty of extraction after removal that affects the intraoperative maneuvers and time. * Contraindication to any laparoscopy like any medical condition worsened by pneumoperitoneum or the Trendelenburg position. * Contraindication to general anesthesia as all laparoscopic procedures are done under GA. * Contraindication to non-steroidal anti-inflammatories, paracetamol, or tramadol.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative painat 24 hours ± 2 hour after the interventionThe pain will be assessed by a numeric rating scale of 0-10

Secondary

MeasureTime frameDescription
Operative timeintraoperativethe time between the start of the incision up to the cutaneous closing of the trocar orifices
the need for conversion to laparotomyintraoperativethe need for conversion to laparotomy
the need to add an additional trocarintraoperativethe need to add an additional trocar

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026